Table 2.

Univariate & Multivariate analyses for the adverse outcome in the derivation cohort

Characteristics	OR (95% CI) Univariate analysis	P-value	OR (95% CI) Multivariate analysis	P-value
Age, years	1.075 (1.066–1.082)	<0.001	1.064 (1.051–1.077)	< 0.001
Sex, Female vs Male	1.420 (1.178–1.711)	<0.001	1.097 (0.686–1.756)	0.699
Smoker, No vs Yes	1.200 (1.001–1.438)	0.049	0.831 (0.653–1.058)	0.133
Drinker, No vs Yes	1.194 (0.973–1.466)	0.090	0.893 (0.690–1.158)	0.394
SBP, mmHg	0.983 (0.979–0.987)	<0.001	0.992 (0.986–0.998)	0.011
DBP, mmHg	0.952 (0.945–0.959)	<0.001	0.988 (0.978–0.998)	0.016
BFP, %	1.052 (1.037–1.068)	<0.001	0.981 (0.942–1.021)	0.339
BMI, kg/m2
18.5–24	Ref.	Ref.
<18.5	1.119 (0.551–2.273)	0.756
≥24	0.876 (0.736–1.043)	0.137
TC, mmol/L	1.322 (1.230–1.421)	<0.001	1.139 (1.039–1.248)	0.005
TG, mmol/L	1.180 (1.123–1.241)	<0.001	1.110 (1.041–1.183)	0.001
HDL, mmol/L	1.935 (1.482–2.527)	<0.001	1.345 (0.978–1.850)	0.068
Diabetes, n (%)	1.668 (1.391–2.001)	<0.001	0.684 (0.551–0.851)	0.001
Hypertension, n (%)	1.727 (1.438–2.075)	<0.001	0.974 (0.783–1.211)	0.813
CHD, n (%)	4.876 (4.062–5.852)	<0.001	1.914 (1.555–2.356)	<0.001
CKD, n (%)	4.563 (3.791–5.493)	<0.001	1.532 (1.236–1.899)	<0.001
CRD, n (%)	6.014 (4.851–7.455)	<0.001	2.712 (2.140–3.438)	<0.001
Aspirin use, No vs Yes	0.922 (0.768–1.106)	0.380
Clopidogrel, No vs Yes	1.093 (0.906–1.320)	0.352
Thrombolytic, No vs Yes	3.112 (1.875–5.165)	<0.001	1.091 (0.636–1.872)	0.753
Insulin use, No vs Yes	5.368 (4.494–6.412)	<0.001	3.338 (2.709–4.113)	<0.001
Statin use, No vs Yes	1.147 (0.961–1.368)	0.130
Antihypertensive use, No vs Yes	1.163 (0.977–1.385)	0.090
Oxygen therapy, No vs Yes	2.107 (1.771–2.506)	<0.001	1.156 (0.956–1.399)	0.136